Stimuli-Responsive Nanomedicines for the Treatment of Non-cancer Related Inflammatory Diseases

Nanomedicines offer a means to overcome the limitations associated with traditional drug dosage formulations by affording drug protection, enhanced drug bioavailability, and targeted drug delivery to affected sites. Inflamed tissues possess unique microenvironmental characteristics (including excessive reactive oxygen species, low pH levels, and hypoxia) that stimuli-responsive nanoparticles can employ as triggers to support on-demand delivery, enhanced accumulation, controlled release, and activation of anti-inflammatory drugs. Stimuli-responsive nanomedicines respond to physicochemical and pathological factors associated with diseased tissues to improve the specificity of drug delivery, overcome multidrug…

• FD
  Fonds De La Recherche Scientifique - FNRS

  Award: 40000747
• UD
  Università degli Studi di Padova

  Awards: MALF_STARS_MUR24_01, MALF_BIRD24_02
• CS
  China Scholarship Council
• HM
  H2020 Marie Skłodowska-Curie Actions

  Award: 887609
• HE
  HORIZON EUROPE European Research Council

  Award: 101163931